Skip to Content
  • Article
  • Open Access

31 July 2025

15 Pages

S100A14 as a Potential Biomarker of the Colorectal Serrated Neoplasia Pathway

,
,
,
,
,
,
,
,
…
1
Laboratory of Translational Gastroenterology, GIGA Institute, University of Liège, 4000 Liège, Belgium
2
GIGA Bioinformatics, GIGA Institute, University of Liège, 4000 Liège, Belgium
3
Hepato-Gastroenterology and Digestive Oncology, University Hospital of Liège (CHU), 4000 Liège, Belgium
4
Pathological Anatomy and Cytology, University Hospital of Liège (CHU), 4000 Liège, Belgium

Abstract

Accounting for 15–30% of colorectal cancer cases, the serrated pathway remains poorly characterized compared to the adenoma–carcinoma sequence. It involves sessile serrated lesions as precursors and is characterized by BRAF mutations (BRAFV600E), CpG island hypermethylation, and microsatellite instability (MSI). Using label-free proteomics, we compared normal tissue margins from patients with diverticular disease, sessile serrated lesions, low-grade adenomas, and high-grade adenomas. We identified S100A14 as significantly overexpressed in sessile serrated lesions compared to low-grade adenomas, high-grade adenomas, and normal tissues. This overexpression was confirmed by immunohistochemical scoring in an independent cohort. Gene expression analyses of public datasets showed higher S100A14 expression in BRAFV600E-mutated and MSI-H colorectal cancers compared to microsatellite stable BRAFwt tumors. This finding was confirmed by immunohistochemical scoring in an independent colorectal cancer cohort. Furthermore, single-cell RNA sequencing analysis from the Human Colon Cancer Atlas revealed that S100A14 expression in tumor cells positively correlated with the abundance of tumoral CD8+ cytotoxic T cells, particularly the CD8+ CXCL13+ subset, known for its association with a favorable response to immunotherapy. Collectively, our results demonstrate for the first time that S100A14 is a potential biomarker of serrated neoplasia and further suggests its potential role in predicting immunotherapy responses in colorectal cancer.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.